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Abstract
Background
Despite on-going advances in medical treatment, the burden of disease of pneumonia
remains high. We aimed to determine the association of the qSOFA score with in-hospital
mortality, length of hospitalisation, and admission to the intensive care unit (ICU) in patients
with pneumonia. Further, in a subgroup analysis, the outcomes were compared for qSOFA
in comparison to other risk scores, including the CURB-65 and SIRS scores.
Methods
In a retrospective analysis, admission data from the ED of the Bern University Hospital,
Switzerland, were screened to identify patients admitted for pneumonia. In addition to clini-
cal characteristics, qSOFA and CURB-65 scores and SIRS criteria were assessed and eval-
uated with respect to the defined study outcomes.
Results
527 patients (median age 66 IQR 50–76) were included in this study. The overall in-hospital
mortality was 13.3% (n = 70); 22.0% (n = 116) were transferred to the ICU. The median
length of hospitalisation was 7 days (IQR 4–12). In comparison to qSOFA-negative patients,
qSOFA-positive patients had increased odds ratios for in-hospital mortality (OR 2.6, 95%:
1.4, 4.7, p<0.001) and ICU admission (3.5, 95% CI: 2.0. 5.8, p<0.001) and an increased
length of stay (p<0.001). For ICU admission, the specificity of qSOPA-positivity (2) was
82.1% and sensitivity 43.0%. For in-hospital mortality, the specificity of qSOPA-positivity
(2) was 88.9% and sensitivity 24.4%.
In the subgroup analysis (n = 366). The area under the receiver operating curve for ICU
admission was higher for qSOFA than for the CURB-65 score (p = 0.013). The evaluated
scores did not differ significantly in their prognostication of in-hospital mortality (p>0.05).
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Conclusions
The qSOFA score is associated with in-hospital mortality, ICU admission and length of hos-
pitalisation in ED patients with pneumonia. Subgroup analysis revealed that qSOFA is supe-
rior to CURB-65 in respect to prognostication of ICU admission.
Introduction
Pneumonia is defined as an acute infection of the pulmonary parenchyma, presenting with an
acute infiltrate in the chest X-ray [1, 2]. Despite on-going advances in medical treatment, the
burden of disease of pneumonia remains significant [3]. Even in developed countries, the inci-
dence of pneumonia is still as high as 9.7 per 1000 persons, with a hospitalisation rate of 46.5%
and 30-day mortality of 12.9% in patients with community-acquired pneumonia [3]. The case-
fatality rate increases to over 50% in patients with pneumonia-related sepsis/septic shock [3,
4]. Therefore, early diagnosis of patients with pneumonia-associated sepsis/septic shock seems
paramount.
In 2016, the third international consensus on sepsis definitions was published [5]. The aim
of the consensus was to take into account emerging knowledge on immune function in sepsis,
where sepsis was defined as a dysregulated host response to an external pathogen [5]. This new
definition also aims to make criteria for diagnosis of sepsis more specific than the proposed
SIRS criteria published in the prior 1992 2nd international consensus, which are of rather low
specificity and lead to a high percentage of false positives [5]. This led to a new sepsis defini-
tion; a change in sequential organ failure (SOFA) score of more than two points with either
proven or suspected infection is diagnostic [5]. However, calculation of SOFA scores requires
sequential laboratory work-up and is therefore not useful for bedside screening of patients
with suspected sepsis [5, 6]. Therefore, the consensus committee has proposed the quick
sequential organ failure score (qSOFA)—which is based on rapidly assessable vital parameters,
including respiratory rate, mental status, and systolic blood pressure [6]. Since the proposal of
qSOFA by the third international consensus, several studies have been performed to evaluate
qSOFA in critically ill patients in various settings [6–17]. qSOFA is also useful in predicting
the outcome prediction abilities in populations in the general emergency department (ED) or
intensive care unit (ICU) [18]. However, it is also critical to validate this score in subgroups of
critically ill patients and this has hardly been attempted. In addition, qSOFA must be com-
pared to other disease-specific scores for outcome prediction.
The primary aim of this study is to evaluate the predictive performance of qSOFA in
patients with pneumonia for the primary outcome of in-hospital mortality. Additional aims
were to assess whether qSOFA-positive patients exhibited increased ICU admission rate and
length of hospital stay. Moreover, we performed a subgroup analysis of these outcomes to
compare the diagnostic power of qSOFA with that of CURB-65, SIRS and clinically diagnosed
sepsis.
Methods
Setting
The study site was the emergency department (ED) of Bern University Hospital (Inselspital),
with a caseload of more than 40,000 patients per year.
qSOFA in pneumonia
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Data collection and eligibility criteria
Our data analysis comprised adult patients admitted to the emergency department (ED) of
Bern University Hospital between 1 June 2011 and 31 May 2013 and with the primary diagno-
sis of pneumonia. Patients were identified using the appropriate search string in the patients’
diagnosis or in the medical history field of our computerised patient database (E-Care, ED
2.1.3.0, Turnhout, Belgium).
All adult patients of 16 years or older presenting with the diagnosis of pneumonia were eli-
gible for study inclusion. Patients with admissions not related to pneumonia, patients with
duplicate records, or with incomplete data sets for the calculation of qSOFA were excluded
from the study. Patients with restrictions to treatment, e.g. reasons against ICU admission,
were not excluded from the analysis.
Data extraction
The following clinical data were extracted from medical records: type of pneumonia (commu-
nity-acquired/nosocomial), time since start of symptoms, history of fever, history of diarrhoea,
history of delirium, history of myalgia, and risk factors for pneumonia [19] (chronic obstruc-
tive pulmonary disease (COPD), diabetes mellitus, liver disease, chronic renal failure, severe
cardiac disease, immunosuppression, active neoplasia, smoking, alcoholism). In addition, we
recorded whether patients were judged to be septic or diagnosed with sepsis by the attending
emergency physician in the health reports. Furthermore, we recorded vital parameters (first
recorded value), laboratory findings, microbiological sampling, and results, as well as duration
of hospitalisation, intensive care unit (ICU) admissions, and in-hospital mortality. Demo-
graphic data, such as gender and age, were also assessed.
Definitions
Pneumonia. Pneumonia was diagnosed by clinical examination together with laboratory
and radiological work-up, as defined by our hospital standard of care. Appropriate microbio-
logical evaluations and treatment were also based on this standard.
ICU admission. ICU admissions included primary ICU admissions (from the ED to the
ICU), as well as secondary ICU admissions (from the general ward to the ICU).
qSOFA. The definition of the Surviving Sepsis Campaign 2016 was used to calculate the
qSOFA score [5]: the qSOFA score was the sum of 1 point for a Glasgow Coma Scale (GCS) of
14 or less, 1 point for a systolic blood pressure of 100 mmHg or less, and 1 point for a respira-
tion rate of 22/min or more.
CURB-65. The CURB score is a pneumonia-specific disease severity score that is widely
used [20]. The CURB score stratifies patients into five strata, with increasing risk of mortality
between the strata [20]. The CURB and its revised version, the CURB-65 score, have been vali-
dated in several studies and exhibit high negative predictive value in patients with pneumonia
[20–22].
In the calculation of CURB-65, one point is scored for each of the following items: i) pres-
ence of confusion—defined as a GCS of 14 or less, ii) blood urea nitrogen of greater than
7mmol/l, iii) respiratory rate of 30/min or more, iv) a systolic blood pressure of less than
90mmHg or diastolic of 60mmHg or less, and v) age of 65 years or more [20]. A CURB-65
score of two or more differentiates patients with a high risk of mortality (9.1%) from those
with a low (1.7%) risk of mortality. A CURB-65 score of 2 and more was therefore used as a
cut-off and defined as positive.
SIRS. The systemic inflammatory response syndrome was part of the 1992 second inter-
national consensus on sepsis and is still widely used in clinical practise [23].
qSOFA in pneumonia
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Criteria for diagnosis of SIRS are as follows: i) body temperature of above 38˚C or below
36˚C, ii) a heart rate of more than 90/min, iii) presence of hyperventilation defined by a respi-
ratory rate of above 20/min or a partial pressure of CO2 of less than 32mmHg, iv) and a white
blood cell count of above 12,000 cells/μL or less than 4,000/μl [23, 24].
Clinical judgement. If the diagnosis or medical history field of the patient’s records con-
tained the terms”sepsis” or “septic”, one point was attributed for clinical judgement. This “clin-
ical judgement” point was attributed solely on the basis of the doctor’s documentation,
independent of whether the old or the new sepsis definition was fulfilled.
Threshold values. qSOFA, CURB-65, and SIRS criteria were considered positive when
the patient scored two or more points [5, 21, 24].
Ethical considerations
The study was approved by the regional ethics committee of the Canton of Bern, Switzerland
(KEK: 09-07-13). Individual informed consent was waived by the ethics committee.
Statistical analysis
Stata1 13.1 (StataCorp, The College Station, Texas, USA) was used for statistical analysis. All
continuous variables were presented as medians with 25th- 75th interquartile ranges (IQR).
Categorical variables were shown with frequency accompanied by its proportion. The Mann-
Whitney U test and the Kruskal-Wallis test were used to compare interval variables between
two and more than two groups, e.g. the qSOFA-positive and qSOFA-negative groups. Com-
parisons of categorical variables between the qSOFA-positive and qSOFA-negative groups
were performed with Fisher’s exact test. Predictive values of CURB-65 and qSOFA scores were
calculated. The equality of the area under the receiver operating curves (AUC) was tested
using the roccomp command to compare the diagnostic performance of the CURB-65 score,
clinical judgement, and SIRS criteria with a qSOFA score in predicting in-hospital mortality or
the need for ICU admission [25]. A p-value of<0.05 was considered significant.
Results
Patients’ demographics
Of the 612 patients with a diagnosis of pneumonia, 527 had complete datasets to calculate the
qSOFA score and were eligible for study inclusion. The CONSORT flow chart is given (Fig 1).
The study population consists of 64.5% (n = 340) male patients; the median age was 66
years (IQR 50–76). Patient characteristics are given in Table 1. The diagnosis of community-
acquired pneumonia was made in 476 patients (90.3%), while 51 patients (9.7%) suffered from
nosocomial pneumonia. The most common risk factors were cardiovascular disease (n = 180,
34.2%) and smoking (n = 174, 33.0%), followed by COPD (n = 133, 25.2%). The median time
since symptom onset was three days (IQR 2–5). Fever was the most common symptom
(n = 289, 54.8%). Four hundred and sixty six (n = 466, 69.4%) patients were hospitalised. Over-
all in-hospital mortality was 13.3% (n = 80); 22.0% (n = 116) patients were admitted to the
ICU and the median length of stay was 7 days (IQR 4–12).
qSOFA assessment
qSOFA score was positive in 86 patients (16.3%). Patients with a positive qSOFA score did not
differ significantly in respect to age, sex, or risk factors for pneumonia from patients with a
negative qSOFA score (all p>0.05). Characteristics of qSOFA positive and qSOFA negative
patients are depicted in Table 2. Patients with a positive qSOFA had significantly fewer days
qSOFA in pneumonia
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since onset of symptoms (p = 0.016), a higher proportion of delirium and myalgia (p<0.001),
and more often suffered from nosocomial pneumonia (p = 0.029) than patients who were
qSOFA-negative. Furthermore, patients with a positive qSOFA score had significantly more
positive blood cultures (p<0.001) and positive results of the pneumococcus antigen test
(p = 0.003). There was a significant positive association between clinically suspected sepsis and
a positive qSOFA score (p<0.001).
In comparison to qSOFA-negative patients, qSOFA-positive patients had increased odds
for in-hospital mortality (OR 2.6, 95%:1.4, 4.7, p<0.001), ICU admission (3.5, 95% CI: 2.0. 5.8,
p<0.001) and an increased length of hospital stay (7, IQR 4–12 vs. 10 IQR 6–16 days, p<0.001).
Predictive value of qSOFA score
The sensitivity of qSOFA in predicting in-hospital mortality and ICU admission was low—
ranging from 15.5%-50.0% for in-hospital mortality and 28.9%-63.6% for ICU admission. The
specificity ranged from 87.5%-89.5% for in-hospital mortality and 78.9%-90.1% for ICU
admission (see Fig 2).
The area under the receiver operating curve (AUC) of qSOFA was 0.58 (95% CI: 0.52, 0.66)
to predict in-hospital mortality and 0.66 (95% CI 0.62, 0.72) for ICU admissions. For a com-
prehensive comparison of the distribution of the outcomes in the different qSOFA categories,
see Table 3.
Patients with a qSOFA score of three points had a high ICU admission rate of 63.6%, with
mortality of 54.6%. A qSOFA score of three points increases the probability of ICU admission
by about 20% (LR+ 3.0) and of in-hospital mortality by about 28% (LR+ 4.4) [26].
Fig 1. CONSORT flow chart.
https://doi.org/10.1371/journal.pone.0188913.g001
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The highest Youden index (= sensitivity + specificity-1) was found for a qSOFA score3 in
both in-hospital mortality (Youden index = 0.42) and ICU admission (Youden index = 0.43).
Subgroup analysis—Comparison of qSOFA to other outcome prediction
scores
A subgroup analysis was performed; this excluded patients with an incomplete dataset to cal-
culate CURB-65 (blood nitrogen missing in 161 patients) or SIRS criteria (leucocytes missing
in 2 and temperature in 18 patients).
Table 1. Patient characteristics.
Characteristics
N 527 (100.0)
Sex, [n (%)]
Males 340 (64.5)
Females 187 (35.5)
Age (years), [median (IQR)] 66 (50–76)
Risk factors, [n (%)]
Chronic obstructive pulmonary disease 133 (25.2)
Diabetes mellitus 93 (17.6)
Liver disease 38 (7.2)
Chronic renal insufficiency 134 (25.4)
Cardiovascular disease 180 (34.2)
Neoplasia, any type 125 (23.7)
Immunosuppressive therapy 101 (19.2)
Smoking history 174 (33.0)
History of alcoholism 39 (7.4)
Time since symptom onset (days), [median (IQR)] 3 (2–5)
Clinical presentation, [n (%)]
Fever 289 (54.8)
Diarrhoea 45 (8.5)
Delirium 38 (7.2)
Myalgia 97 (18.4)
Type of Pneumonia, [n (%)]
Community acquired 476 (90.3)
Nosocomial acquired 51 (9.7)
Microbiological diagnostics, [n (%)]
Blood culture obtained 416 (78.9)
Blood culture positive 58 (13.9)
Urine, legionella antigen positive* 11 (2.9)
Urine, pneumococcus antigen positive# 35 (13.0)
Sputum, obtained 110 (20.9)
Sputum, pathological 89 (80.9)
Clinical judgment, [n (%)]
Clinically suspected sepsis 73 (13.9)
Outcome parameter
In-hospital mortality, [n (%)] 70 (13.3)
ICU admission, [n (%)] 116 (22.0)
Length of stay (days), [median (IQR)] 7 (4–12)
Urine antigen taken in *n = 271 / #n = 192 patients
https://doi.org/10.1371/journal.pone.0188913.t001
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Three hundred and forty-six patients (n = 346) with a median age of 68 years (IQR 58–77),
an in-hospital mortality of 14.5% (n = 50), an ICU admission rate of 27.2% (n = 94), and a
median length of stay of eight days (IQR 5–13) were included in the subgroup analysis.
qSOFA- and CURB-65-positive patients had increased in-hospital mortality (OR 2.7, 95%
CI 1.3, 5.5, p = 0.002 and OR 3.3, 95% 1.8, 5.9, p<0.001), while clinical judgement and positive
SIRS criteria were not associated with in-hospital mortality (OR 1.5, 95% CI 0.6, 3.1, p = 0.279
and OR 0.89, 95% CI 0.5, 1.8, p = 0.746).
Table 2. Comparison of qSOFA-positive and qSOFA-negative patients.
Characteristics qSOFA<2 qSOFA2 P
n 441 (83.7) 86 (16.3)
Sex, [n (%)]
Male 292 (66.2) 48 (55.8)
Female 149 (33.8) 38 (44.2) 0.084
Age, [median (IQR)] 66 (52–75) 66 (50–80) 0.527
Risk factors, all >0.05
Days since symptom onset, [median (IQR)] 3 (2–6) 2.5 (2–5) 0.016
Clinical presentation, [n (%)]
Fever 246 (55.8) 43 (50) 0.345
Diarrhoea 34 (7.7) 11 (12.8) 0.139
Delirium 20 (4.5) 18 (20.9) <0.001
Myalgia 92 (20.9) 5 (5.8) <0.001
Type of Pneumonia, [n (%)]
Community acquired 404 (91.6) 72 (83.7)
Nosocomial acquired 37 (8.4) 14 (16.3) 0.029
Diagnostics, [n (%)]
Blood culture positive 37 (10.8) 21 (28.4) <0.001
Urine, legionella antigen 10 (3.2) 1 (1.6) 1.000
Urine, pneumococcus antigen 22 (9.8) 13 (28.3) 0.003
Sputum, pathological 75 (80.6) 14 (82.4) 1.000
Clinical judgment, [n (%)]
Clinically suspected sepsis 43 (9.8) 30 (34.9) <0.001
Length of stay (days), [median (IQR)] 7 (4–12) 10 (6–16) <0.001
ICU admission, [n (%)] 79 (17.9) 37 (43) <0.001
In-hospital mortality, [n (%)] 49 (11.1) 21 (24.4) <0.001
https://doi.org/10.1371/journal.pone.0188913.t002
Fig 2. Receiver operating characteristic curve of qSOFA predicting A) in-hospital mortality, B) ICU admission.
https://doi.org/10.1371/journal.pone.0188913.g002
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For all evaluated 4 scores, score positive patients had a significant higher ICU admission
rate and a significantly increased length of hospitalisation (p all <0.05).
Table 4 summarises the diagnostic performance of qSOFA, SIRS, and CURB-65 scores as
well as clinical judgement in respect to in-hospital mortality and ICU admission.
No significant differences were found between the AUC for in-hospital mortality or ICU
admissions for qSOFA vs. SIRS (p = 0.054 / p = 0.143) or for qSOFA vs. clinically suspected
sepsis (p = 0.186 / p = 0.262).
qSOFA had a significantly higher AUC than CURB-65 in predicting ICU admission
(p = 0.013), but not in predicting in-hospital mortality (p = 0.156).
Comparison of included and excluded patients
In the primary outcome analysis, 13.9% (n = 85) of the eligible patients had to be excluded
because of missing data, which was mainly a missing documented respiratory rate (n = 77).
There was no significant association between being excluded and any studied risk factor for
pneumonia (p>0.1). Furthermore, no significant differences were found in regard to in-hospi-
tal mortality (p = 0.221) or ICU admission (p = 0.396). The length of hospitalisation was signif-
icantly (p = 0.030) increased in the included patients (median 8, IQR 5–14) compared to the
excluded patients (median 7, IQR 4–11).
Discussion
Key findings
This study analysed the predictive performance of qSOFA in ED patients with pneumonia in
regard to in-hospital-mortality, ICU admission and length of hospital stay. The predictive abil-
ity of qSOFA was presented and compared to other outcome scores in a subgroup analysis.
Our results show that qSOFA predicts in-hospital mortality, ICU admission, and length of
stay in patients admitted with pneumonia. The sensitivity of qSOFA was low. qSOFA was
superior to CURB-65 in predicting ICU admissions in ED patients with pneumonia. The eval-
uated scores were equally effective in respect to in-hospital mortality.
qSOFA assessment
Several recently published trials investigated the predictive performance of qSOFA in patients
in the general emergency department population with suspected infection [7, 16, 17, 27–30];
some of these studies also investigated patients with pneumonia [17, 28, 30]. Other authors
Table 3. Length of hospital stay, ICU admission and in-hospital mortality in patients with different qSOFA score categories in patients with pneu-
monia (n = 527).
Length of stay [days] ICU admission In-hospital mortality
n Median (IQR) p Frequency (%) p Frequency (%) p
qSOFA
0 191 6.0 (3–10) 19 (10.0) 20 (10.5)
1 250 8.0 (5–13) 60 (24.0) 29 (11.6)
2 75 10.0 (6–17) 30 (40.0) 15 (20.0)
3 11 6.0 (4–9) <0.001 7 (63.6) <0.001 6 (54.6) 0.001
qSOFA
<2 441 7.0 (4–12) 79 (17.9) 49 (11.1)
2 86 10.0 (6–16) <0.001 37 (43.0) <0.001 21 (24.4) 0.003
Total 527 7.0 (4–12) 22 (22.0) 70 (13.3)
https://doi.org/10.1371/journal.pone.0188913.t003
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have shown that qSOFA has significant predictive ability in respect to in-hospital mortality in
patients with pneumonia [17, 28, 30]. However, the AUC values in published studies on this
topic are highly disparate [17, 28, 30]. Although our study only showed a moderate AUC for
in-hospital mortality in patients with pneumonia, others have found AUCs ranging from 0.7
to 0.81 for prediction of in-hospital mortality [17, 28, 30].
Two studies were restricted to community-acquired pneumonia in Germany and Spain
and found an AUC for 30-day-mortality of 0.70 [28] and in-hospital-mortality of 0.69 [30].
The higher AUC might be explained by the exceptionally low mortality rates (4% and 6%) in
Table 4. Diagnostic performance of different scores predicting A) ICU admission and B) In-hospital mortality (n = 346).
Sensitivity
[%]
Specificity [%] Likelihood ratio + Likelihood ratio - Area under ROC
A) ICU ADMISSION
qSOFA*
1 34.2 (28.9) 87.5 (90.1) 2.7 (2.9) 0.8 (0.8)
2 48.4 (43.0) 77.7 (82.1) 2.2 (2.4) 0.7 (0.7)
3 70.0 (63.6) 74.1 (78.9) 2.7 (3.0) 0.4 (0.5) 0.668 (0.672)
Suspected sepsis*
yes 54.7 (32.8) 79.1 (91.5) 2.6 (3.9) 0.6 (0.7) 0.629 (0.621)
CURB-65
1 28.3 77.8 1.3 0.9
2 32.4 78.7 1.5 0.9
3 38.1 75.3 1.5 0.8
4 57.1 74.1 2.2 0.6
5 80.0 73.6 3.0 0.3 0.586
SIRS
1 28.4 84.8 1.9 0.8
2 31.4 82.7 1.8 0.8
3 36.6 78.8 1.7 0.8
4 39.5 74.6 1.6 0.8 0.615
B) IN-HOSPITAL MORTALITY
qSOFA*
1 15.5 (14.9) 87.5 (89.5) 1.2 (1.4) 1.0 (1.0)
2 26.6 (24.4) 88.3 (88.9) 2.3 (2.2) 0.8 (0.9)
3 50.0 (54.5) 86.6 (87.5) 3.7 (4.4) 1.9 (0.5) 0.587 (0.592)
Suspected sepsis*
yes 14 (18.6) 85.5 (86.9) 0.9 (1.4) 1 (0.9) 0.553 (0.527)
CURB-65
1 15.9 92.1 2.0 0.9
2 19.2 90.9 2.1 0.9
3 30.2 89.0 2.8 0.8
4 35.7 86.4 2.6 0.8
5 40.0 85.9 2.8 0.7 0.650
SIRS
1 18.8 86.5 1.4 0.9
2 15.7 97 5.2 0.9
3 14 84.6 0.9 1
4 13.4 84.9 0.9 1 0.497
* corresponding predictive values of the full set (n = 527) are shown in brackets
https://doi.org/10.1371/journal.pone.0188913.t004
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these studies [28, 30]. The latter can be explained by the restriction to community-acquired
pneumonia only, whereas in our study 9.7% of the patients suffered from nosocomial pneumo-
nia, which is associated with a higher mortality rate [31].
A further study set in China even found an AUC of 0.81 for 28-day mortality [17]. Although
the high AUC in the latter study is striking, the results are not comparable to Western studies,
as the 28-day-mortality for hospitalised patients was extremely high (54%), with ICU admis-
sion of 85% [17].
Despite the good predictive ability of qSOFA in general ED patients [7, 16, 27], the prog-
nostic accuracy of the qSOFA score was much smaller for in-hospital mortality among adults
admitted to the ICU with suspected infection [29]. In the ICU setting, the SOFA score shows
the best predictive ability [29]. Remarkably however, in ICU patients, the AUC (0.607) of a
positive qSOFA in predicting in-hospital mortality [29] was very close to the findings in this
study (0.608), whereas the AUC for predicting mortality was significantly higher in less ill
patient populations [7, 16]. Taken together, these results may indicate that qSOFA is more use-
ful in predicting mortality in populations with lower mortality rates.
As found by other authors, qSOFA has low sensitivity in respect to the outcomes in this
study [17, 30, 32]. Nonetheless, the sensitivity is comparable to that of other scores, such as
CURB-65 or SIRS.
qSOFA score was associated with ICU admission in this study. This is in accordance with
other studies on general ED patients admitted with suspected infection [7, 16], and also with a
study that investigated patients presenting with pneumonia [17].
qSOFA score is associated with the length of stay in hospital in this study. While it has been
shown that qSOFA was associated with the length of hospitalisation in ICU patients with suspected
infection [29], this is the first study to show an association with length of stay in ED patients.
Comparison of qSOFA to other outcome prediction scores
To our knowledge, this is the first study that compared CURB-65 and qSOFA in regard to ICU
admissions in ED patients diagnosed with pneumonia. One other study compared CRB and
CRB-65 with qSOFA in respect to ICU admissions, without taking into account blood urea
nitrogen [17]. While the authors of this study found that the number of ICU admissions was
higher when q-SOFA was used for predicting ICU admission than with CRB-65(p<0.01), no
significant difference (p>0.05) between these two scores was found in the AUC, which ranged
from 0.57 to 0.68 (only range given). The difference might be explained by differences in the
procedures for ICU admission procedures in other health systems and the relatively low hospi-
talisation rate of (53%) in the study by Chen et al. [17], which indicates that their study popula-
tion might have been different from ours. In the setting of a university hospital in Europe, our
result suggest, that qSOFA is superior to CURB-65 in predicting ICU admission.
qSOFA and CURB-65 score are equal in their predictive abilities for in-hospital mortality.
However, the AUC for in-hospital mortality for CURB-65 was non-significantly higher than
the AUC for qSOFA. Other studies also found non-significant differences, with higher AUC
for CURB-65 [17, 28]. This should certainly be further investigated, as qSOFA has the major
advantage that it requires no laboratory work-up to calculate the score. It could then be used
for the bedside assessment of patients presenting with pneumonia within minutes of arrival.
CURB-65 on the other hand needs a urea value, which takes roughly one hour of laboratory
work-up, in addition to the time spent to draw the blood sample. This may waste essential
time in managing critically ill patients with pneumonia. However, time is a crucial issue when
treating patients with sepsis. qSOFA therefore might provide a more rapid and cheaper alter-
native to evaluating disease severity in patients presenting with pneumonia. The addition of an
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age component (one point for an age of 65 or more) to qSOFA for instance increased its pre-
dictive ability for 30-day mortality in patients with pneumonia [28].
Surprisingly, SIRS criteria were not associated with in-hospital mortality in this study. Two
studies have compared SIRS criteria with qSOFA, one on patients with suspected infection
outside the ICU (7) and another very recently published study on patients with pneumonia
[30]. These showed that qSOFA was superior to SIRS criteria in the prediction of mortality. In
our study, the AUC for in-hospital mortality was higher in qSOFA than with SIRS, but the dif-
ference was not significant. In a study that compared SIRS, qSOFA and SOFA in respect to in-
hospital mortality in ICU patients, SOFA gave significantly better results, with no difference
between SIRS and qSOFA [29]. Thus, qSOFA may be superior to SIRS criteria for predicting
in-hospital mortality in ED patients with pneumonia. However, on the ICU, SOFA might be
the optimal choice to investigate in-hospital mortality.
Study limitations and strength
Our study has several limitations. Firstly, the study was retrospective design and used medical
records. Thus, no standardised form for each patient was completed at the time of admission.
It is therefore possible that risk factors or symptoms were not recorded by the treating physi-
cian, even though they were present in the patient. This also led to a significant percentage of
excluded patients due to incomplete data sets for the calculation of qSOFA. However, in the
main analysis, a comparison of in- vs. excluded patients did not show significant differences in
regard to in-hospital mortality or risk factors for pneumonia, so that selection bias is unlikely.
On the other hand, in the subgroup analysis of all patients with complete data to calculate SIRS
criteria and CURB-65 –blood urea nitrogen and respiratory rate were often missing.
The case definition of pneumonia was based on the diagnosis documented in the medical
report of the patient. While the diagnosis is usually based on radiography and the clinical pre-
sentation of the patient, a diagnosis bias cannot be excluded. This could be a source of a possi-
ble selection bias.
The results are restricted to patients primarily diagnosed with pneumonia in the ED. Fur-
thermore, treatment restriction was not taken into account, which might have biased the asso-
ciation of ICU admission and the different scores.
Conclusions
qSOFA predicts in-hospital mortality, length of hospitalisation, and ICU admission in ED
patients presenting with pneumonia. qSOFA is superior to CURB-65 in respect to ICU admis-
sions. In respect to in-hospital mortality, the evaluated scores were equivalent. qSOFA has the
advantage of being a pure bedside test. As it requires no laboratory testing, it may be more
practical than the CURB-65 score or SIRS criteria for routine clinical work.
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